Fig. 5
From: Comprehensive analysis of UPK3B as a marker for prognosis and immunity in pancreatic adenocarcinoma
Immunotherapy outcome prediction and validation. (A) Correlation analysis of UPK3B with immune checkpoints. (B) TIDE scoring based on UPK3B. (C) The prognostic significance of UPK3B was validated in three additional datasets. *p < 0.05;**p < 0.01;***p < 0.001.
